Digestive Disease Interventions
DOI: 10.1055/s-0043-1760730
Review Article

Complications of 90Y Radioembolization Treatment for Liver Tumors

Mason Eghbali
1   Ronald Reagan UCLA Medical Center, Los Angeles, California
2   Division of Interventional Radiology, Department of Radiology, University of California Los Angeles, Los Angeles, California
,
Zachary M. Haber
1   Ronald Reagan UCLA Medical Center, Los Angeles, California
,
Ravi N. Srinivasa
1   Ronald Reagan UCLA Medical Center, Los Angeles, California
,
Siddharth A. Padia
1   Ronald Reagan UCLA Medical Center, Los Angeles, California
› Author Affiliations

Abstract

Y90 radioembolization has been demonstrated to be a safe and effective treatment for patients with HCC and for certain liver metastases, such as neuroendocrine tumors, uveal melanomas, and breast cancer. Although the procedure is relatively safe, the complications associated with radioembolization vary greatly in their locations, presentation, and severity. This review aims to discuss and increase awareness of the potential complications associated with radioembolization.



Publication History

Received: 25 October 2022

Accepted: 08 December 2022

Article published online:
27 January 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA